9.630

-1.370 (-12.45%)
Range - - -   (-%)
Open -
Previous Close 11.000
Buy Price -
Buy Volume -
Sell Price -
Sell Volume -
Volume -
Value -
Remark
Measurement Type Value
EPS (USD) -7.667
Trailing EPS (USD) -7.862
NAV (USD) 6.156
Cash In Hand (USD) 6.043
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 1.564
Price / Cash In Hand 1.594
Issued & Paid-up Shares 1,842,720
Treasury Shares -
Market Cap (M) 17.745
Par Value (USD) n.a.
Beta - 75 Days -4.918
R-Squared - 75 Days(%) 2.67
Beta - 500 Days -1.35
R-Squared - 500 Days(%) 0.21
ISIN Code
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 04 Aug 2021 04:00.
Data powered by
View All Events

About INTEC PARENT INC

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs. The Company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson’s disease patients. Its pipeline also comprises The Accordion Pill-Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Furthermore under research is Accordion Pill-Undisclosed Drug for the prevention and treatment of small bowel non-steroidal anti-inflammatory drug (NSAID) induced ulcers.

There are 1 follower

Followers
46